Remember meForgot password?
    Log in with Twitter

article imageMushroom toxin fights cancer

By Tim Sandle     Apr 29, 2018 in Science
Scientists have taken one of the most deadly toxins, extracted from a fungus, and demonstrated that the chemical can be used with the treatment of certain types of cancer.
The fungus in question is the death-cap mushroom. The toxin from the mushroom has been used in several historical murders. It now has a potential life-saving use, in the form of cancer treatment.
The fungus (Amanita phalloides) produces a mycotoxin called α‐amanitin. The mushroom is responsible for the majority of fatal mushroom poisonings worldwide. Here just 30 grams (equivalent to 1.1 ounces), or half a cap, of this mushroom is estimated to be enough to kill a human.
Scientists have succeeded in synthesizing the toxin as a medical drug. This process was complicated, but the researchers eventually overcame the challenges and synthesized the death-cap killer compound.
According to Bioscience Technology, α‐amanitin toxin is so deadly because it functions as a potent inhibitor of RNA polymerase II. This is the enzyme that is primarily responsible for transcribing genes into the messenger molecule RNA.
By using α-amanitin bound to antibodies against different tumor molecules, scientists were able to cure mice of pancreatic cancer. This success has led to the commencement of a human trial.
Should the human trial be successful, going forwards a new way will need to be developed to obtain α-amanitin. The current processing of harvesting mushrooms and extracting the toxin is too variable and time-consuming. Moreover, this process limits the quantity of toxin that can be extracted.
The focus is on synthesizing the toxin. However, synthetic production methods are affected by α-amanitin’s atypical bicyclic structure. The researchers had to overcome several obstacles in order to produce sufficient amounts of α-amanitin in the laboratory. Even here, because of the highly toxic nature, the scientists had to limit this production to under a milligram. Going forward, and with enhanced safety measures, it is hoped the process can be scaled up.
With the scale-up and further investigations into the toxicity, the researchers aim to attenuate the toxicity and also to potentially improve α-amanitin’s activity against tumors.
The research has been published in the Journal of the American Chemical Society. The research paper is titled “Synthesis of the Death-Cap Mushroom Toxin α-Amanitin.”
More about Cancer, Tumors, Fungi, Toxins
More news from
Latest News
Top News